Did management answer the analysts?
12 analyst questions audited, 4 evaded or deflected.
View Claim Ledger →Bajaj Finserv's Q4 FY26 consolidated results were impacted by temporary MTM losses from insurance investments, with reported revenue growth of 6% to ₹3,858 crore and PAT growth of 5% to ₹2,539 crore.
✓ Verified against BSE filing
Bajaj Finserv's Q4 FY26 consolidated results were impacted by temporary MTM losses from insurance investments, with reported revenue growth of 6% to ₹3,858 crore and PAT growth of 5% to ₹2,539 crore. Excluding MTM, revenue grew 14% and PAT 24%. General insurance saw muted GWP growth due to tactical reduction in crop and motor amid pricing pressure, with combined ratio elevated at 113.6%. Life insurance showed strong VNB growth of 29% to ₹709 crore and NBM expansion to 24.5%, driven by protection and group business. Lending subsidiaries Bajaj Finance and Bajaj Housing Finance delivered robust AUM growth of 22% and 23% respectively. Emerging businesses like Bajaj Finserv Health grew revenue 41%, while Bajaj Markets saw planned degrowth due to platform migration. Management guided for improved growth in life insurance and break-even for Bajaj Markets by end of FY27. Key risk: persistency dips in life insurance and elevated claims in government health business could pressure profitability.
12 analyst questions audited, 4 evaded or deflected.
View Claim Ledger →0 delivered, 0 close, 2 missed.
View Promises →Persistency dips in life insurance
View Risks →Full transcript text is available on this route.
Read Transcript →Muted growth due to tactical reduction in crop and motor amid pricing pressure.
Strong growth driven by protection and group business, with NBM expanding to 24.5%.
Crossed ₹5 lakh crore milestone, driven by diversified business model.
Growth driven by home loans (18%), LAP (24%), and LRD (44%).
Management expects continued margin expansion driven by product mix shift towards term and protection, with term aspirational target of 10%+ of mix.
The marketplace business aims to achieve break-even by the end of the current fiscal year, with revenues recovering post-platform migration.
The health business expects to reach operating break-even in about two years, based on current growth trajectory of 40-50%.
The asset management company expects to break even when AUM reaches approximately ₹1 lakh crore, with current equity mix at 59%.
Management expects margin expansion to continue but at a slower pace due to base effects; GST impact pushed back strategy by 2-3 quarters.
Bajaj Life expects to mitigate about 3.25% of the 4.5% GST impact by Q4 FY26 through product and commission adjustments.
A separate company (Bajaj Finserv Alternatives) will launch alternative investment funds and portfolio management services targeting high-net-worth clients.
Regulatory approvals initiated for a pension fund management business and a branch in GIFT City.
Underwriting losses widened due to higher claims from government health schemes, though management considers it a timing variance.
Analyst raised concern about pricing pressure; management acknowledged but said they will reduce exposure where pricing is inadequate.
Management cited lack of clarity on IFRS 17 assumptions and tax implications, leading to forbearance request; could cause reporting volatility.
Industry-wide motor OD loss ratios have risen due to lower IDV post-GST and inflation in repair costs; Bajaj General is also affected.
After a year of ~50% average VNB growth, management expects growth to slow as base effects kick in.
Analyst raised concern about pricing pressure in motor and health segments; management acknowledged industry-wide correction but did not provide specific mitigation timeline.
Mentioned in Q2 FY26, Q3 FY26
Industry-wide motor OD loss ratios have risen due to lower IDV post-GST and inflation in repair costs; Bajaj General is also affected.
Management expects continued margin expansion driven by product mix shift towards term and protection, with term aspirational target of 10%+ of mix.
Persistency ratios declined across certain cohorts, in line with industry trends, which could impact future VNB if not reversed.
View Risks →